V01.00 (National Front page and page 4 amended to reflect national 03 September 2015 Community Pharmacy NHS England authorisation for delivery of the Advanced Service) national Community Pharmacy Advanced Service V02.00 New Pharmacy Influenza PGD for the 2016/2017 21 July 2016 season to replace IM Influenza PGD v01.00 (National Community Pharmacy Advanced Service). V03.00 New Pharmacy Influenza Vaccination PGD for the 11 July 2017 2017/2018 season to replace Pharmacy Influenza PGD v02.00. Amendments include: addition of morbidly obese individuals to the inclusion criteria and deletion of related text in the additional information section exclusion of people who have received a dose of influenza vaccine for the current season statement that patients should be reassured that the inactivated vaccine cannot cause influenza but vaccine will not provide protection for about 14 days and does not protect against other respiratory viruses that often circulate during the flu season minor rewording for clarity V04.00 Pharmacy Influenza Vaccination PGD amended to 01 November 2017 include immunisation of health and social care staff, employed by a registered residential care/nursing home or registered domiciliary care provider, who are directly involved in the care of vulnerable patients/clients who are at increased risk from exposure to influenza. V05.00 Pharmacy Influenza Vaccination PGD amended to: 10 August 2018 refer to updated include vaccines available for 2018/19 season, including the adjuvanted trivalent influenza vaccine Fluad® and related information regarding this product include a table of recommended vaccine choice provide further guidance on route of administration for individuals with bleeding disorders or on anticoagulants to vaccine incident guidelines in off-label and storage sections include minor rewording, layout and formatting changes for clarity and consistency with other PHE PGD templates PGD Development This PGD has been developed by the following health professionals on behalf of PHE: Developed by: Name Signature Date
V01.00 (National Community Pharmacy Advanced Service) Front page and page 4 amended to reflect national NHS England authorisation for delivery of the national Community Pharmacy Advanced Service 03 September 2015 V02.00 New Pharmacy Influenza PGD for the 2016/2017 season to replace IM Influenza PGD v01.00 (National Community Pharmacy Advanced Service). 21 July 2016 V03.00 New Pharmacy Influenza Vaccination PGD for the 2017/2018 season to replace Pharmacy Influenza PGD v02.00. Amendments include: addition of morbidly obese individuals to the inclusion criteria and deletion of related text in the additional information section exclusion of people who have received a dose of influenza vaccine for the current season statement that patients should be reassured that the inactivated vaccine cannot cause influenza but vaccine will not provide protection for about 14 days and does not protect against other respiratory viruses that often circulate during the flu season minor rewording for clarity 11 July 2017 V04.00 Pharmacy Influenza Vaccination PGD amended to include immunisation of health and social care staff, employed by a registered residential care/nursing home or registered domiciliary care provider, who are directly involved in the care of vulnerable patients/clients who are at increased risk from exposure to influenza. 01 November 2017 V05.00 Pharmacy Influenza Vaccination PGD amended to: refer to updated include vaccines available for 2018/19 season, including the adjuvanted trivalent influenza vaccine Fluad® and related information regarding this product include a table of recommended vaccine choice provide further guidance on route of administration for individuals with bleeding disorders or on anticoagulants to vaccine incident guidelines in off-label and storage sections include minor rewording, layout and formatting changes for clarity and consistency with other PHE PGD templates 10 August 2018 PGD Development This PGD has been developed by the following health professionals on behalf of PHE: Developed by: Name Signature Date